Documents

Hills Pharmacy, LLC; Decision and Order

Federal Register · Notice · Jul 28, 2016

at 482-83. Next, Mr. … Oregon, 546 U.S. 243, 274 (2006) (citing United States v. Moore, 423 U.S. 122, 135, 143 (1975)). Id. (emphasis added).

Mark P. Koch, D.O.; Decision and Order

Federal Register · Notice · Apr 3, 2014

DEA, 419 F.3d at 482; Morall v. DEA, 412 F.3d at 176 (quoting NLRB v. Columbian Enameling & Stamping Co., 306 U.S. 292, 299-300, 59 S.Ct. 501, 505 (1939)). … NLRB, 340 U.S. at 496).

Larry C. Daniels, M.D.; Decision and Order

Federal Register · Notice · Nov 5, 2021

Moore, 423 U.S. 122, 135, 143 (1975)). * [According to the CSA's implementing regulations, a lawful] controlled substance prescription is valid only when it is “issued for a legitimate medical purpose … Moore, 423 U.S. 122, 135 (1975). To ensure that controlled substances remain in legitimate channels, the CSA creates a “closed regulatory” scheme. Gonzales v.

Schedules of Controlled Substances: Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II

Federal Register · Rule · Aug 22, 2014

Moore, 423 U.S. 122 (1975) (holding registered physicians may be prosecuted for violation of the CSA when their activities fall outside the usual course of professional practice). … Moore, 423 U.S. 122 (1975).

Dewey C. Mackay, M.D.; Revocation of Registration

Federal Register · Notice · Aug 16, 2010

Oregon, 546 U.S. 243, 274 (2006) (citing United States v. Moore, 423 U.S. 122, 135, 143 (1975)). … McKinney, 73 FR 43260, 43265 n.22 (2008); see also Moore, 423 U.S. at 142-43 (noting that evidence established that physician “exceeded the bounds of `professional practice,' ” when “he gave inadequate

Emran Mohammad, RN, APRN, CNP; Decision and Order

Federal Register · Notice · Sep 11, 2026

Oregon, 546 U.S. 243, 270 (2006). … Drug Enf't Admin., 419 F.3d 477, 482 (6th Cir. 2005).

Lawrence E. Stewart, M.D.; Decision and Order

Federal Register · Notice · Aug 17, 2016

Moore, 423 U.S. 122, 135, 143 (1975)). … Moore, 423 U.S. 122, 139 (1975)).

David D. Moon, D.O.; Decision and Order

Federal Register · Notice · Apr 27, 2017

Flowers, 547 U.S. 220, 225 (2006) (citing Dusenbery v. United States, 534 U.S. 161, 170 (2002)). … Flowers, supra, 547 U.S. at 226 (citing Mullane v. Central Hanover Bank & Trust Co., 339 U.S. 306, 314 (1950)).

Michael S. Moore, M.D.; Suspension of Registration

Federal Register · Notice · Aug 1, 2011

DEA, 419 F.3d 477, 482 (6th Cir. 2005); see also Morall v. DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005). … Co., Inc., 411 U.S. 182, 188 (1973)), cert. denied, __ U.S. __, 129 S. Ct. 1033 (2009).

Brewster Drug, Inc.; Decision and Order

Federal Register · Notice · Apr 3, 2020

MacKay, 664 F.3d at 816 (quoting Volkman, 567 F.3d at 222); see also Hoxie, 419 F.3d at 482. … Gonzales, 546 U.S. at 259. “Because ‘past performance is the best predictor of future performance, ALRA Labs, Inc. v.

Lesly Pompy, M.D.; Decision and Order

Federal Register · Notice · Oct 28, 2019

Oregon, supra, 546 U.S. at 269-71. … Oregon, supra, 546 U.S. at 274.

Edge Pharmacy; Decision and Order

Federal Register · Notice · Oct 19, 2016

See also U.S. v. $29,410.00 in U.S. Currency, 600 Fed. … Oregon, 546 U.S. 243, 274 (2006) (citing United States v. Moore, 423 U.S. 122, 135, 143 (1975)). Id. (emphasis added).

Decision and Order: Zelideh I. Cordova-Velazco, M.D.

Federal Register · Notice · Dec 6, 2018

(same), cert. denied, 506 U.S. 820 (1992). … DEA, 419 F.3d 477, 482 (6th Cir. 2005); see also Kevin Dennis, M.D., 78 FR 52787, 52974 (2013); MacKay v. DEA, 664 F.3d 808, 816 (10th Cir. 2011).

George Pharmacy, Inc.; Decision and Order

Federal Register · Notice · Apr 11, 2022

MacKay, 664 F.3d at 816 (quoting Volkman, 567 F.3d at 222); see also Hoxie, 419 F.3d at 482. … Oregon, 546 U.S. 243, 274 (2006).

Kathy A. Morall, M.D.; Revocation of Registration

Federal Register · Notice · Oct 6, 2004

Moore, 423 U.S. 122, 135, (1975). In some cases, revocation of a DEA registration is an appropriate measure for failure to maintain adequate controlled substance records and inventories.

Alexander Drug Company, Inc.; Revocation of Registration

Federal Register · Notice · Apr 6, 2001

Moore, 423 U.S. 122, 135, 96 S. Ct. 335, 342 (1975). … Green Drugs, 905 F.2d 694, 698 (3d Cir. 1990), cert. denied, 498 U.S. 985, 111 S.Ct. 518 (1990); United States v. James Little, 59 F. Supp. 2d 177, 183 (D. Mass. 1999).

Morning Star Pharmacy & Medical Supply 1; Decision And Order

Federal Register · Notice · Aug 19, 2020

Tr. 242, 335, 423-25, 647-49; Tex. Health & Safety Code § 481.074(k)(3), (7). … Drug Enf't Admin., 419 F.3d 477, 482 (6th Cir. 2005). Furthermore, there is no requirement to consider a factor in any given level of detail. Trawick v.

Frank Joseph Stirlacci, M.D.; Decision and Order

Federal Register · Notice · Jul 27, 2020

Drug Enf't Admin., 419 F.3d 477, 482 (6th Cir. 2005)). … United States, 527 U.S. 1 (1999)), and a false statement to federally insured financial institutions ( United States v. Wells, 519 U.S. 482 (1997)).

Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV

Federal Register · Rule · Jul 2, 2014

It was first approved for use in the United States by the U.S. Food and Drug Administration (FDA) in 1995 under the trade name ULTRAM®. … Moore, 423 U.S. 122 (1975) (holding registered physicians may be prosecuted for violation of the CSA when their activities fall outside the usual course of professional practice).

Trenton F. Horst, D.O.; Decision and Order

Federal Register · Notice · Jul 14, 2015

NLRB, 340 U.S. 474, 496 (1951) (“The `substantial evidence' standard is not modified in any way when the Board and its examiner disagree . . . . … DEA, 419 F.3d 477, 482 (6th Cir. 2005); see also Morall v. DEA, 412 F.3d 165, 173-74 (D.C. Cir. 2005).